• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物组成与儿童川崎病血管炎发展的相关性。

Correlation of gut microbial compositions to the development of Kawasaki disease vasculitis in children.

机构信息

State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science & Technology, Macau SAR, China.

Department of Pediatrics, Kiang Wu Hospital, Macau SAR, China.

出版信息

Future Microbiol. 2020 May;15:591-600. doi: 10.2217/fmb-2019-0301. Epub 2020 Jun 3.

DOI:10.2217/fmb-2019-0301
PMID:32490694
Abstract

Here, we hypothesize that dysbiotic gut microbiota might contribute to the development of Kawasaki disease (KD), a pediatric disease with unknown etiology. This is the second report on gut microbiota composition in KD patients. 16S amplicon sequencing was performed on fecal DNA samples and revealed predominance of bacterial pathogens, such as , ,  and , in the gut of KD patients, but absent or suppressed after immunoglobulin/antibiotics therapy. In addition, beneficial bacteria propagated after the therapy. We conclude that prevalence of Fusobacteria,  and might contribute to KD pathogenesis.

摘要

在这里,我们假设肠道菌群失调可能导致川崎病(KD)的发生,这种儿科疾病的病因尚不清楚。这是关于川崎病患者肠道微生物组组成的第二份报告。对粪便 DNA 样本进行 16S 扩增子测序,结果显示川崎病患者肠道中以细菌病原体为主,如 、 、 、 等,但在免疫球蛋白/抗生素治疗后消失或受到抑制。此外,治疗后有益菌大量繁殖。我们的结论是,梭杆菌属、 、 和 的流行可能与 KD 的发病机制有关。

相似文献

1
Correlation of gut microbial compositions to the development of Kawasaki disease vasculitis in children.肠道微生物组成与儿童川崎病血管炎发展的相关性。
Future Microbiol. 2020 May;15:591-600. doi: 10.2217/fmb-2019-0301. Epub 2020 Jun 3.
2
Alteration of the oral and gut microbiota in patients with Kawasaki disease.川崎病患者口腔和肠道微生物群的改变。
PeerJ. 2023 Jul 10;11:e15662. doi: 10.7717/peerj.15662. eCollection 2023.
3
Metagenomic analysis demonstrates distinct changes in the gut microbiome of Kawasaki diseases children.宏基因组分析表明川崎病患儿肠道微生物组有明显变化。
Front Immunol. 2024 Jul 22;15:1416185. doi: 10.3389/fimmu.2024.1416185. eCollection 2024.
4
A metagenomic study of the gut microbiome in Behcet's disease.贝赫切特病肠道微生物组的宏基因组学研究。
Microbiome. 2018 Aug 4;6(1):135. doi: 10.1186/s40168-018-0520-6.
5
Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease.川崎病患儿肠道菌群改变与全身炎症相关。
Sci Rep. 2020 Sep 3;10(1):14525. doi: 10.1038/s41598-020-71371-6.
6
Having older siblings is associated with gut microbiota development during early childhood.有哥哥姐姐与幼儿期肠道微生物群的发育有关。
BMC Microbiol. 2015 Aug 1;15:154. doi: 10.1186/s12866-015-0477-6.
7
Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity.婴儿肠道微生物组的改变与呼吸道合胞病毒疾病的严重程度有关。
BMC Microbiol. 2020 Jun 1;20(1):140. doi: 10.1186/s12866-020-01816-5.
8
Profiling the Gastrointestinal Microbiota.肠道微生物组学分析。
Methods Mol Biol. 2021;2283:83-92. doi: 10.1007/978-1-0716-1302-3_10.
9
Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease.肠道微生物失调作为川崎病易感性因素。
Front Immunol. 2023 Oct 31;14:1268453. doi: 10.3389/fimmu.2023.1268453. eCollection 2023.
10
The Microbiome and Metabolome of Preterm Infant Stool Are Personalized and Not Driven by Health Outcomes, Including Necrotizing Enterocolitis and Late-Onset Sepsis.早产儿粪便的微生物组和代谢组具有个体特异性,不受健康结果(包括坏死性小肠结肠炎和晚发性败血症)驱动。
mSphere. 2018 Jun 6;3(3). doi: 10.1128/mSphere.00104-18. Print 2018 Jun 27.

引用本文的文献

1
Unveiling the gut-heart potential connection: microbiota's role in kawasaki disease and coronary artery lesions.揭示肠道与心脏的潜在联系:微生物群在川崎病和冠状动脉病变中的作用。
Front Cell Infect Microbiol. 2025 May 29;15:1560083. doi: 10.3389/fcimb.2025.1560083. eCollection 2025.
2
Ozone exposure is positively correlated with the occurrence of Kawasaki disease in Chinese children.在中国儿童中,臭氧暴露与川崎病的发生呈正相关。
Pediatr Res. 2025 May 13. doi: 10.1038/s41390-025-04116-8.
3
Interplay of gut microbiota in Kawasaki disease: role of gut microbiota and potential treatment strategies.
肠道微生物群在川崎病中的相互作用:肠道微生物群的作用及潜在治疗策略
Future Microbiol. 2025 Mar;20(4):357-369. doi: 10.1080/17460913.2025.2469432. Epub 2025 Feb 27.
4
Gut Microbiota Alterations in Patients With Kawasaki Disease.川崎病患者的肠道微生物群改变
Arterioscler Thromb Vasc Biol. 2025 Mar;45(3):345-358. doi: 10.1161/ATVBAHA.124.321201. Epub 2025 Jan 23.
5
Association of recent antibiotic exposure and coronary artery lesions in Kawasaki disease: nationwide study.川崎病近期抗生素暴露与冠状动脉病变的关联:全国性研究。
Front Pediatr. 2024 Nov 1;12:1467288. doi: 10.3389/fped.2024.1467288. eCollection 2024.
6
[Characteristics of intestinal microbiota in the acute phase of Kawasaki disease in infants and children].[婴幼儿川崎病急性期肠道微生物群的特征]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Oct 15;26(10):1101-1107. doi: 10.7499/j.issn.1008-8830.2405111.
7
A two sample mendelian randomization analysis investigates causal effects between gut microbiome and immune related Vasculitis.一项两样本孟德尔随机化分析研究了肠道微生物组与免疫相关血管炎之间的因果关系。
Sci Rep. 2024 Aug 13;14(1):18810. doi: 10.1038/s41598-024-68205-0.
8
Metagenomic analysis demonstrates distinct changes in the gut microbiome of Kawasaki diseases children.宏基因组分析表明川崎病患儿肠道微生物组有明显变化。
Front Immunol. 2024 Jul 22;15:1416185. doi: 10.3389/fimmu.2024.1416185. eCollection 2024.
9
Alteration of the oral and gut microbiota in patients with Kawasaki disease.川崎病患者口腔和肠道微生物群的改变。
PeerJ. 2023 Jul 10;11:e15662. doi: 10.7717/peerj.15662. eCollection 2023.
10
The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease.肠道内产生短链脂肪酸的微生物减少与川崎病的炎症激活有关。
Front Immunol. 2023 Jun 15;14:1124118. doi: 10.3389/fimmu.2023.1124118. eCollection 2023.